Blue Sea Capital completes sale of leading Croatian glass pharmaceutical packaging company to Japanese Nipro Corporation
Blue Sea Capital, a regional private equity fund, has successfully completed the sale of its 100 percent ownership stake in Piramida, a leading Croatian manufacturer of glass pharmaceutical packaging, to Nipro PharmaPackaging International NV, a subsidiary of Nipro Corporation which has its headquarters in Japan.…
European Investment Fund approves an investment in Blue Sea Capital Fund II
Blue Sea Capital is pleased to announce that the European Investment Fund (“EIF”) Board of Directors approved an investment in Blue Sea Capital Fund II, subject to satisfactory legal negotiations. EIF is expected to become an anchor investor in Blue Sea Capital Fund II…
Mid Europa and Blue Sea Capital complete Exit from Knjaz Miloš
Blue Sea Capital is pleased to announce that it has completed the sale of Knjaz Miloš, a major player in the production of mineral water and non-alcoholic beverages in Serbia and the surrounding region, to a joint venture between Karlovarské Minerální Vody and PepsiCo, Inc …
Mid Europa and Blue Sea Capital complete Exit from Bambi
Blue Sea Capital is pleased to announce that it has completed the sale of Bambi, the leading biscuit producer in countries of former Yugoslavia with its iconic Plazma brand, to Coca-Cola Hellenic Bottling Company …
KMV and PepsiCo Acquire Knjaz Miloš from Mid Europa and Blue Sea Capital
Blue Sea Capital is pleased to announce the signing of an agreement for sale of Knjaz Miloš, the leading producer of mineral water and non-alcoholic beverages in Serbia and the surrounding region, to a joint venture between Karlovarské Minerální Vody (“KMV”) and PepsiCo, Inc. (“PepsiCo”). The transaction is subject to customary competition authority clearance and is expected to close in Q3 2019 …
Coca Cola Hellenic acquires Bambi from Mid Europa and Blue Sea Capital
Blue Sea Capital is pleased to announce the signing of an agreement for sale of Bambi, the leading biscuit producer in the countries of former Yugoslavia, to Coca-Cola HBC AG (“Coca-Cola HBC”). The transaction is subject to customary competition authority clearance and is expected to close in Q2 2019 …
Mid Europa completes the acqusition of a majority stake in Medigroup
Mid Europa Partners (“Mid Europa”), the leading private equity investor in Central and Eastern Europe, announced today that it completed the acquisition of a majority stake in MediGroup. The seller, Blue Sea Capital, retained a 45% stake in the Company. …
Mid Europa acquires majority stake in Medigroup
Mid Europa Partners (“Mid Europa”), the leading private equity investor in Central and South Eastern Europe, announced today that it has entered into an agreement to acquire a majority stake in MediGroup (“MediGroup” or the “Company”). The seller, Blue Sea Capital, will retain a 45% stake in the Company. The transaction is subject to customary competition clearance and is expected to close in Q2 2018. …
MediGroup starts national expansion via acquisition of healthcare centre Dr. Cvjetković in Novi Sad
Blue Sea Capital is pleased to announce that MediGroup has acquired Dr. Cvjetković health centre, the largest healthcare operation in Novi Sad. Dr. Cvjetković is the leader in private healthcare services in the Vojvodina region with proven track record and tradition spanning over 20 years, rendering almost 80,000 medical procedures annually to its patients. …
MediGroup enters anti-aging and dermatology sector through a partnership with Ioanna Batsialou
Blue Sea Capital is pleased to announce that MediGroup entered into a partnership with Dr Ioanna Batsialou, a pioneer of anti-ageing medicine and a leader in dermatology in Serbia. Ioanna MediGroup clinic (“the Clinic”) is based in Belgrade and delivers anti-aging and dermatology treatments, building on Dr. Batsialou’s broad experience in anti-ageing medicine. …
Blue Sea Capital participates in the acquisition of three leading food and beverages companies in Serbia
Blue Sea Capital is pleased to announce its participation in the investment consortium led by Mid Europa Partners, which has now completed the acquisition of three leading food and beverages companies in Serbia: Imlek, Bambi and Knjaz Milos. Imlek is the biggest independent dairy producer in Central Eastern Europe with an impressive portfolio of dairy products. Bambi is a leading confectionary producer with its trademark „Plazma“ biscuit commanding exceptional brand loyalty. Knjaz Milos is a leading producer of and a leading brand in mineral water in Serbia.…
Blue Sea Capital completes investment in ophthalmology clinic Milos Klinika
Blue Sea Capital is pleased to announce that it completed its sixth investment, the acquisition of ophthalmology clinic Milos Klinika. Milos Klinika is one of the leading regional ophthalmology clinics, primarily involved in cataract and cataract related surgeries, vitrectomy and LASIK surgeries. In 2013 it performed almost 4,000 surgeries and 9,000 examinations. Sasa Galic, Managing Partner of Blue Sea Capital, said: “We are pleased that we have completed this investment, an investment which underlines our belief in the strong growth prospects of both the ophthalmology medical area and the overall private healthcare sector in Serbia.”…
Blue Sea Capital invests in ophthalmology clinic Milos Klinika
Blue Sea Capital is pleased to announce the signing of an agreement to acquire Milos Klinika, a leading ophthalmology clinic based in Belgrade, Serbia. Milos Klinika (“the Clinic“) prides itself on its exceptional medical team led by Prof. Dr Zoran Kuljača, a distinguished and recognised ophthalmology expert. The Clinic delivers the highest standard of care to its patients across the region.…
MediGroup acquires hospital building
Blue Sea Capital announces MediGroup’s acquisition of the hospital building situated at Milutina Milankovica 3, Belgrade. MediGroup, which currently consists of leading health centres Dr Ristic and Jedro and gynaecological hospital (with maternity ward) Jevremova, is a leading private provider of healthcare services in Serbia.…
The opening of Serbia’s largest private general hospital facility
Blue Sea Capital is pleased to announce that its Serbian healthcare platform MediGroup has opened MediGroup general hospital. The hospital is equipped to the latest healthcare technology standards, and offers superior in-patient accommodation and healthcare treatment to its rapidly growing number of patients from Belgrade, as well as from across the country.…
MediGroup completes investment in Health Centre Jedro
Blue Sea Capital is pleased to announce that its Serbian health care platform MediGroup today completed its acquisition of Dom Zdravlja Jedro from Delta Generali Insurance, adding the third largest outpatient provider in Serbia to MediGroup. In addition, MediGroup signed an agreement with Delta Generali, expanding cooperation with the leader in private health insurance in Serbia.…
MediGroup invests in Health Centre Jedro
Blue Sea Capital is pleased to announce that its Serbian health care platform MediGroup today signed an agreement to acquire Dom Zdravlja Jedro from Delta Generali Insurance, adding one of the largest outpatient providers in Serbia to MediGroup and expanding cooperation with Delta Generali, the leader in private health insurance in Serbia.…
The launch of Serbia’s first private health care platform
The Serbian health care market has traditionally been characterised by a large number of independent medical providers, not necessarily cooperating with each other or sharing expertise and resources. This pattern, with the recent creation of MediGroup, is now subject to an exciting change.…
Blue Sea invests in hospital Jevremova
Blue Sea Capital is pleased to announce its investment into Jevremova, the Serbia’s leading gynaecological and IVF clinic. …
EBRD supports Piramida
The EBRD is investing €3.6 million to strengthen the Croatian pharmaceutical packaging producer Piramida d.o.o. and in plans to expand the company’s production. While €2.7 million will be used for balance sheet restructuring, the remaining €0.9 million will finance additional production facilities.…
Blue Sea Capital Fund C.V. to enter the private healthcare sector in Serbia
Blue Sea Capital Fund C.V. (“Blue Sea Capital”) is pleased to announce the closing of the acquisition of Dom Zdravlja Dr Ristic (“Dr Ristic”), the largest private outpatient polyclinic in Serbia, today.…
Blue Sea Capital Fund C.V. completes the acquisition of Piramida d.d. in Croatia
Blue Sea Capital Fund C.V. (“Blue Sea Capital”) announced that it has completed the acquisition of a 100% stake in Piramida d.d. (“Piramida”), the leading regional manufacturer of ampoules and vials for the pharmaceutical industry, based in Zagreb (Croatia).…